MedPath

MPAC-study: A feasibility study of the co-registration of MRI-imaging with PAthologicalassessment of primary tumor extension in patients with uterine Cervical tumors.

Recruiting
Conditions
Validation of MRI for measuring uterine involvement of uterine cervical cancer
Registration Number
NL-OMON27815
Lead Sponsor
AMC amsterdam
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

All patients with early uterine cervical cancer (FIGO stages < IIA) for whom a Wertheim
Okabayashi procedure and a MRI is planned.

Exclusion Criteria

1. MRI: claustrophobia, pacemaker, medicine pump, neurostimulator, cochlear implants,
other metal implants in the pelvis that would disturb the image. In some cases
surgical clips in the brain are contra-indicated, this will be evaluated conform standard
protocol;

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Accuracy of linear extension.
Secondary Outcome Measures
NameTimeMethod
Acccuracy of tumor volume.
© Copyright 2025. All Rights Reserved by MedPath